SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function.
Brunk F, Moritz A, Nelde A, Bilich T, Casadei N, Fraschka SAK, Heitmann JS, Hörber S, Peter A, Rammensee HG, Singh H, Walz J, Maurer D, Wagner C.
Brunk F, et al. Among authors: moritz a.
Eur J Immunol. 2021 Nov;51(11):2651-2664. doi: 10.1002/eji.202149290. Epub 2021 Sep 13.
Eur J Immunol. 2021.
PMID: 34424997
Free PMC article.